Savior Lifetec Corporation (4167.TWO)
TWD 17.65
(-9.95%)
TWD 17.65
(-9.95%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 457.95 Million TWD | -56.04% |
| 2022 | 1.04 Billion TWD | -15.01% |
| 2021 | 1.22 Billion TWD | -18.63% |
| 2020 | 1.5 Billion TWD | -17.2% |
| 2019 | 1.81 Billion TWD | 8.71% |
| 2018 | 1.67 Billion TWD | -6.21% |
| 2017 | 1.78 Billion TWD | 35.46% |
| 2016 | 1.31 Billion TWD | -20.32% |
| 2015 | 1.65 Billion TWD | -10.1% |
| 2014 | 1.83 Billion TWD | 34.23% |
| 2013 | 1.37 Billion TWD | 24.18% |
| 2012 | 1.1 Billion TWD | 8.16% |
| 2011 | 1.02 Billion TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 453.17 Million TWD | -1.04% |
| 2024 Q2 | 473.97 Million TWD | 4.59% |
| 2023 Q3 | 413.82 Million TWD | -6.55% |
| 2023 Q1 | 944.37 Million TWD | -9.35% |
| 2023 Q2 | 442.84 Million TWD | -53.11% |
| 2023 FY | 457.95 Million TWD | -56.04% |
| 2023 Q4 | 457.95 Million TWD | 10.66% |
| 2022 Q2 | 1.78 Billion TWD | 34.59% |
| 2022 Q3 | 1.02 Billion TWD | -42.77% |
| 2022 Q4 | 1.04 Billion TWD | 1.82% |
| 2022 Q1 | 1.32 Billion TWD | 8.36% |
| 2022 FY | 1.04 Billion TWD | -15.01% |
| 2021 Q3 | 1.33 Billion TWD | -2.37% |
| 2021 Q1 | 1.39 Billion TWD | -7.36% |
| 2021 Q2 | 1.36 Billion TWD | -2.33% |
| 2021 FY | 1.22 Billion TWD | -18.63% |
| 2021 Q4 | 1.22 Billion TWD | -7.88% |
| 2020 Q1 | 1.96 Billion TWD | 8.2% |
| 2020 Q2 | 1.94 Billion TWD | -1.27% |
| 2020 Q3 | 1.54 Billion TWD | -20.48% |
| 2020 FY | 1.5 Billion TWD | -17.2% |
| 2020 Q4 | 1.5 Billion TWD | -2.54% |
| 2019 Q2 | 2.02 Billion TWD | 0.8% |
| 2019 Q4 | 1.81 Billion TWD | -3.85% |
| 2019 FY | 1.81 Billion TWD | 8.71% |
| 2019 Q1 | 2 Billion TWD | 20.09% |
| 2019 Q3 | 1.89 Billion TWD | -6.61% |
| 2018 Q1 | 1.41 Billion TWD | -20.72% |
| 2018 FY | 1.67 Billion TWD | -6.21% |
| 2018 Q4 | 1.67 Billion TWD | 0.18% |
| 2018 Q3 | 1.67 Billion TWD | 6.3% |
| 2018 Q2 | 1.57 Billion TWD | 11.08% |
| 2017 Q3 | 1.43 Billion TWD | -24.51% |
| 2017 FY | 1.78 Billion TWD | 35.46% |
| 2017 Q4 | 1.78 Billion TWD | 24.0% |
| 2017 Q1 | 1.29 Billion TWD | -2.06% |
| 2017 Q2 | 1.9 Billion TWD | 47.75% |
| 2016 Q4 | 1.31 Billion TWD | -0.37% |
| 2016 Q3 | 1.32 Billion TWD | 10.6% |
| 2016 Q2 | 1.19 Billion TWD | -26.56% |
| 2016 Q1 | 1.62 Billion TWD | -1.53% |
| 2016 FY | 1.31 Billion TWD | -20.32% |
| 2015 Q3 | 1.73 Billion TWD | 3.75% |
| 2015 Q4 | 1.65 Billion TWD | -4.88% |
| 2015 Q2 | 1.67 Billion TWD | -10.83% |
| 2015 FY | 1.65 Billion TWD | -10.1% |
| 2015 Q1 | 1.87 Billion TWD | 2.16% |
| 2014 Q3 | 1.74 Billion TWD | 9.61% |
| 2014 Q1 | - TWD | -100.0% |
| 2014 Q2 | 1.59 Billion TWD | 0.0% |
| 2014 FY | 1.83 Billion TWD | 34.23% |
| 2014 Q4 | 1.83 Billion TWD | 5.34% |
| 2013 Q4 | 1.37 Billion TWD | 0.0% |
| 2013 FY | 1.37 Billion TWD | 24.18% |
| 2013 Q1 | 1.31 Billion TWD | 19.46% |
| 2013 Q2 | 1.31 Billion TWD | 0.0% |
| 2012 Q2 | 1.08 Billion TWD | 0.0% |
| 2012 FY | 1.1 Billion TWD | 8.16% |
| 2012 Q4 | 1.1 Billion TWD | -0.36% |
| 2012 Q3 | 1.1 Billion TWD | 2.2% |
| 2011 Q4 | 1.02 Billion TWD | 0.0% |
| 2011 FY | 1.02 Billion TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -6447.855% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 21.513% |
| Level Biotechnology Inc. | 273.2 Million TWD | -67.626% |
| Sagittarius Life Science Corp | 137.82 Million TWD | -232.277% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | -131.911% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 65.511% |
| GlycoNex Incorporation | 276.39 Million TWD | -65.687% |
| VBI | 21.25 Million TWD | -2054.99% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | -45.983% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 11.016% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -2057.529% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | -24.333% |
| Visgeneer Inc. | 185.6 Million TWD | -146.737% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 65.39% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 37.522% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | -282.077% |
| Neith Corporation | 17.43 Million TWD | -2526.955% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 79.611% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -6819.87% |
| Enimmune corporation | 173.46 Million TWD | -164.008% |
| TaiRx, Inc. | 60.62 Million TWD | -655.393% |
| CHO Pharma, Inc. | 110.83 Million TWD | -313.199% |
| EirGenix Inc. | 1.14 Billion TWD | 60.007% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | -308.96% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 10.632% |
| Lin BioScience, Inc. | 167.73 Million TWD | -173.032% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -388.675% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -626.524% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | -267.162% |
| Lukas Biomedical Inc. | 161.05 Million TWD | -184.341% |
| RBC Bioscience Corporation | 513.08 Million TWD | 10.744% |
| BiOptic Inc. | 170.56 Million TWD | -168.497% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -986.287% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -1869.284% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -1607.966% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 53.012% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -5644.568% |
| NaviFUS Corp. | 53.4 Million TWD | -757.581% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 4.887% |
| Sinew Pharma Inc. | 39.71 Million TWD | -1053.137% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -689.05% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | -25.648% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | -101.128% |
| AP Biosciences Inc | 106.65 Million TWD | -329.402% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 87.027% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -1392.64% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | -133.663% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 70.325% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 47.144% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -4837.009% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -720.52% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | -96.583% |
| TCI GENE Inc. | 155.54 Million TWD | -194.415% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -1695.347% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -891.786% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | -39.421% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -605.776% |
| PharmaEngine, Inc. | 91 Million TWD | -403.216% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | -312.797% |
| OBI Pharma, Inc. | 650.44 Million TWD | 29.594% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | -17.181% |
| Acepodia, Inc. | 384.47 Million TWD | -19.113% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -435.29% |